Page last updated: 2024-10-23

azathioprine and Ureteral Neoplasms

azathioprine has been researched along with Ureteral Neoplasms in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Ureteral Neoplasms: Cancer or tumors of the URETER which may cause obstruction leading to hydroureter, HYDRONEPHROSIS, and PYELONEPHRITIS. HEMATURIA is a common symptom.

Research Excerpts

ExcerptRelevanceReference
"The patient was given a diagnosis of refractory anemia with excess of blasts in transformation (RAEB in T), and treated with idarubicin and cytosine arabinoside."2.40[Myelodysplastic syndrome (RAEB in T) developed in a renal allograft recipient]. ( Akiyama, M; Inaba, T; Katori, Y; Maki, K; Nakagawa, M; Sawada, K; Shimazaki, C; Shiraishi, J; Sudo, Y; Takada, O, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shiraishi, J1
Sudo, Y1
Katori, Y1
Akiyama, M1
Takada, O1
Maki, K1
Sawada, K1
Inaba, T1
Shimazaki, C1
Nakagawa, M1

Reviews

1 review available for azathioprine and Ureteral Neoplasms

ArticleYear
[Myelodysplastic syndrome (RAEB in T) developed in a renal allograft recipient].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:8

    Topics: Anemia, Refractory, with Excess of Blasts; Azathioprine; Humans; Immunosuppressive Agents; Kidney Ne

1998